Logo-jcvtr

J Cardiovasc Thorac Res. 2019;11(2): 132-137. doi: 10.15171/jcvtr.2019.23
PMID: 31384408        PMCID: PMC6669430

Original Article

The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy

Mahdiyar Iravani Saadi 1,2, Mohammad Ali Babaee Beigi 3, Maryam Ghavipishe 3, Maryam Tahamtan 3 * ORCID, Bita Geramizadeh 4, Abdolhossein Zare 2, Ramin Yaghoobi 2

Cited by CrossRef: 10

1- Iravani Saadi M, Salami J, Abdi H, Kheradmand N, Nabi Abdolyousefi E, Torkamani M, Karimi Z, Agah S, Rahimian Z, Manafi A. Expression of interleukin 1, interleukin 27, and TNF α genes in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy: A case‐control study. Health Science Reports. 2022;5(4) [Crossref]
2- Saadi M, Nikandish M, Ghahramani Z, Valandani F, Ahmadyan M, Hosseini F, Rahimian Z, Jalali H, Tavasolian F, Abdolyousefi E, Kheradmand N, Ramzi M. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options. J Egypt Natl Canc Inst. 2023;35(1) [Crossref]
3- Saadi M, Ramzi M, Hosseinzadeh M, Ebrahimi N, Owjfard M, Abdolyousefi E, Hesami Z, Valibeigi B, Zareei N, Tavasolian F, Haghighinejad H, Zare A. Expression Levels of Il-6 and Il-18 in Acute Myeloid Leukemia and Its Relation with Response to Therapy and Acute GvHD After Bone Marrow Transplantation. Indian J Surg Oncol. 2021;12(3):465 [Crossref]
4- Kadhi A, Mohammed F, Nemer G. The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy. Front Cardiovasc Med. 2021;8 [Crossref]
5- Saadi M, Tahmasebijaroubi F, Noshadi E, Rahimikian R, Karimi Z, Owjfard M, Niknam A, Abdolyousefi E, Salek S, Tabrizi R, Jamali E. Dysregulated Expression of MiR-19b, MiR-25, MiR-17, WT1, and CEBPA in Patients with Acute Myeloid Leukemia and Association with Graft versus Host Disease after Hematopoietic Stem Cell Transplantation. South Asian J Cancer. 2022;11(04):346 [Crossref]
6- Li X, Lei Y, Gao Z, Wu G, Gao W, Xia L, Lu J, Shen H. IL-34 affects fibroblast-like synoviocyte proliferation, apoptosis and function by regulating IL-17. Sci Rep. 2021;11(1) [Crossref]
7- Iravani Saadi M, Ramzi M, Hesami Z, kheradmand N, Owjfard M, Nabi Abdolyousefi E, Karimi Z. MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses. VirusDis. 2021;32(4):727 [Crossref]
8- Iravani Saadi M, Moayedi J, Hosseini F, Rostamipour H, Karimi Z, Rahimian Z, Ahmadyan M, Ghahramani Z, Dehghani M, Yousefi K, Kheradmand N, Ramzi M, Fooladivanda N. The Effects of Resveratrol, Gallic Acid, and Piperine on the Expression of miR-17, miR-92b, miR-181a, miR-222, BAX, BCL-2, MCL-1, WT1, c-Kit, and CEBPA in Human Acute Myeloid Leukemia Cells and Their Roles in Apoptosis. Biochem Genet. 2024;62(4):2958 [Crossref]
9- Alieva A, Teplova N, Lyalina V, Shnakhova L, Arakelyan R, Skripnichenko E, Valiev R, Rakhaev A, Shavaeva M, Nikitin I. Interleukin-18 and cardiovascular diseases: a literature review. Medical Journal of the Russian Federation. 2022;28(3):201 [Crossref]
10- Ahmed M, El Amrousy D, Hodeib H, Elnemr S. Neutrophil-to-lymphocyte ratio as a predictive and prognostic marker in children with dilated cardiomyopathy. Cardiol Young. 2023;33(12):2493 [Crossref]
11- Wang J, Xie S, Cheng Y, Li X, Chen J, Zhu M. Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy. Front Cardiovasc Med. 2022;9 [Crossref]